$44.24
0.39[0.89%]
At close: Apr 26
$44.24
0[0.00%]
After Hours: 4:00PM EDT
Ultragenyx Pharmaceutical
(NASDAQ:RARE)Ultragenyx Pharmaceutical Stock (NASDAQ:RARE), Insider Trading Activity
Ultragenyx Pharmaceutical: Insider buying and selling updated today.
Insider Shares Owned
1.778M
Insider Percentage Owned
2.16%
Institutional Shares Held
48.910M
Institutional Percentage Held
59.4%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 19, 2024 | Eric Crombez | EVP AND CHIEF MEDICAL OFFICER | -142 | $44.10 | -$6.26K | SELL | -0.29% | 48.785K | Apr 18 | View |
| Mar 12, 2024 | Richard Thomas Kassberg | CBO & EVP | -11.509K | $49.93 | -$574.64K | SELL | -4.35% | 252.823K | Mar 11 | View |
| Mar 11, 2024 | Matthew Fust | -12.195K | $50.88 | -$620.44K | SELL | -45.07% | 14.86K | Mar 07 | View | |
| Mar 05, 2024 | Karah Parschauer | EVP AND CHIEF LEGAL OFFICER | 15.001K | $53.76 | -$201.92K | GRANT | 28.66% | 67.34K | Mar 01 | View |
| Mar 05, 2024 | Richard Thomas Kassberg | CBO & EVP | 17.472K | $53.75 | -$69.06K | GRANT | 7.08% | 264.332K | Mar 01 | View |
| Mar 05, 2024 | Richard John Pinion | SEE REMARKS | 14.524K | $53.76 | -$227.56K | GRANT | 19.43% | 89.268K | Mar 01 | View |
| Mar 05, 2024 | Alan Theodore Huizenga | SVP, CHIEF ACCOUNTING OFFICER | 13.488K | $53.74 | -$24.83K | GRANT | 48.36% | 41.38K | Mar 01 | View |
| Mar 05, 2024 | Eric Crombez | EVP AND CHIEF MEDICAL OFFICER | 18.162K | $53.76 | -$66.55K | GRANT | 59.03% | 48.927K | Mar 01 | View |
| Mar 05, 2024 | Erik Harris | EVP & CHIEF COMMERCIAL OFFICER | 15.589K | $53.76 | -$256.33K | GRANT | 30.23% | 67.163K | Mar 01 | View |
| Feb 08, 2024 | EMIL KAKKIS | PRESIDENT & CEO | -30K | $45.00 | -$1.35M | SELL | -1.06% | 2.803755M | Feb 07 | View |
| Jan 02, 2024 | EMIL KAKKIS | PRESIDENT & CEO | -30K | $47.87 | -$1.44M | SELL | -1.05% | 2.833755M | Dec 29 | View |
| Oct 24, 2023 | Richard Thomas Kassberg | CBO & EVP | 0 | $19.82 | -$1.03M | SELL-OPTIONS | 0.00% | 246.86K | Oct 23 | View |
| Oct 23, 2023 | EMIL KAKKIS | PRESIDENT & CEO | 0 | $20.19 | -$1.28M | SELL-OPTIONS | 0.00% | 2.863728M | Oct 19 | View |
| Sep 11, 2023 | Alan Theodore Huizenga | SVP, CHIEF ACCOUNTING OFFICER | -163 | $30.90 | -$46.25K | SELL | -0.69% | 23.614K | Sep 07 | View |
| Sep 06, 2023 | Erik Harris | EVP & CHIEF COMMERCIAL OFFICER | -6K | $37.96 | -$227.76K | SELL | -10.47% | 51.281K | Sep 05 | View |
| Sep 06, 2023 | Alan Theodore Huizenga | SVP, CHIEF ACCOUNTING OFFICER | -970 | $37.15 | -$36.03K | SELL | -3.92% | 23.777K | Sep 01 | View |
| Jun 30, 2023 | Corsee Corazon Sanders | DIRECTOR | -585 | $46.76 | -$27.35K | SELL | -6.11% | 8.985K | Jun 30 | View |
| Jun 21, 2023 | Erik Harris | EVP & CHIEF COMMERCIAL OFFICER | -305 | $48.20 | -$14.70K | SELL | -0.53% | 57.281K | Jun 19 | View |
| Jun 09, 2023 | Corsee Corazon Sanders | DIRECTOR | 2.375K | $51.65 | -$76.70K | GRANT | 33.01% | 9.57K | Jun 07 - Jun 08 | View |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.